Knockdown of the β subunit of HIF-1, which inhibits HIF-1 transactivation activity, resulted in the upregulation of PPARγ and UCP2 in NSCLC cells (Figure 4C). The gene discussed is UCP2; the disease is non-small cell lung carcinoma.